The synthesized ligand (3-(2-amino-5-(3,4,5-tri-methoxybenzyl)pyrimidin-4-ylamino)-5,5-dimethylcyclohex-2-enone] [H1L1] was characterized via fourier transform infrared spectroscopy (FTIR), 1H, 13C – NMR, Mass spectra, (CHN analysis), UV-vis spectroscopic approaches. Analytical and spectroscopic techniques like chloride content, micro-analysis, magnetic susceptibility UV-visible, conductance, and FTIR spectra were used to identify mixed ligand complexes. Its (ML13ph) mixed ligand complexes [M= Co (II), Ni (II), Cu (II), Zn (II), and Cd (II); (H1L1) = β-enaminone ligand=L1 and (3ph) =3-aminophenol= L2]. The results demonstrate that the complexes are produced with a molar ratio of M: L1:L2 (1:1:1). To generate the appropriate complex, a tetradentate β-enaminone ligand with N3O donor atoms is coordinated to Co(II), Ni(II), Cu(II), Zn(II), and Cd (II) ions. The synthesized ligand and its mixed ligand complexes have been tested against various pathogenic fungi and bacteria for antifungal and antibacterial activities. In this case, when compared with conventional antibiotic ciprofloxacin, the biological activity regarding such compounds was good.
